Angelini Ventures announced its participation in Hypervision Surgical’s 17 million GBP Series A round. The round was led by Heal Capital and included Angelini Ventures, IP Group, Daycrest, existing investors Heran Partners, Redalpine, LifeX Ventures and Zeiss Ventures, plus strategic investors Sinc fund and Macmillan Cancer Support. The funding is intended to support commercial roll-out, broader clinical adoption and development of a scalable cloud-enabled AI-assisted surgery platform. Tanja Dowe and Rick Mangat will join the board of directors as part of the deal.
About Hypervision Surgical
A pioneer in real-time hyperspectral imaging for surgery. The company develops the Hyperspectral Intelligence platform, which uses on-chip spectral sensors, patented AI analysis and a scalable cloud-based architecture to convert spectral data invisible to the human eye into real-time quantitative indicators of tissue physiology for AI-assisted surgery.
London, United Kingdom
Read Company ProfileFrequently Asked Questions
What type of funding round did Hypervision Surgical raise?
Hypervision Surgical raised a series-a round.
How much did Hypervision Surgical raise in its series-a?
Hypervision Surgical raised $17,000,000 GBP in its series-a.
When did Hypervision Surgical raise its series-a?
Hypervision Surgical raised its series-a on 2026-04-29.
Who invested in Hypervision Surgical's series-a?
The investors in Hypervision Surgical's series-a are: Heal Capital, Angelini Ventures, IP Group, Daycrest, Heran Partners, Redalpine, LifeX Ventures, Zeiss Ventures, Sinc fund, Macmillan Cancer Support.
What type of investment was Hypervision Surgical's series-a?
Hypervision Surgical's series-a was a equity investment.
How will Hypervision Surgical use the funds from its series-a?
Hypervision Surgical plans to use the funds for: accelerate the commercial roll-out of Hypervision’s Hyperspectral Intelligence platform, expand clinical adoption, transform the company’s next-generation hyperspectral sensing technology into a scalable, cloud-enabled platform for AI-assisted surgery.